ArticlePediatric nephrology (Berlin, Germany)2026
PROGRESS Study: Longitudinal analysis of antioxidant status and its relationship with heat shock proteins in children with chronic kidney disease.
Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
backgroundChronic kidney disease (CKD) progresses via complex mechanisms, including oxidative stress and impaired antioxidant defenses. We aimed to investigate longitudinal changes in serum and urinary levels of superoxide dismutase (SOD), catalase, and glutathione in children with CKD, and to assess their relationship with heat shock proteins (HSPs), which we have previously reported to be altered in this population.
methodsA total of 117 children with CKD and 56 healthy children were enrolled in the study. The CKD group was followed prospectively for 24 months. Serum and urinary levels of SOD, catalase, and glutathione were measured using ELISA at baseline, 12 months, and 24 months. Longitudinal changes and associations with kidney outcomes and CKD progression were analyzed using mixed-effects and logistic regression models.
resultsSerum SOD and catalase levels, as well as urinary SOD, catalase, and glutathione levels were higher in the CKD group than in the control group. Serum and urinary SOD and catalase levels steadily decreased over time, similarly to urinary HSP levels. Most antioxidant biomarkers were not significantly associated with longitudinal kidney outcomes. However, higher longitudinal urinary catalase levels were modestly associated with better kidney function over time, and higher baseline urinary catalase was independently associated with a lower risk of CKD progression. In contrast, higher baseline serum SOD levels were associated with an increased risk of progression. Antioxidant biomarkers showed strong correlations with serum and urinary HSP levels.
conclusionAlthough urinary catalase consistently associates with kidney function and CKD progression, most antioxidant biomarkers alone have limited predictive value. Children with CKD show altered antioxidant defenses that decline over time, and their correlations with HSPs suggest that they may act together in response to oxidative stress.
Indexed as
Identifiers
42503547What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.